Announce Date | 05/07/2025 |
EPS Normalized Actual | $0.55 (Beat by $0.03) |
EPS GAAP Actual | $0.55 (Beat by $0.03) |
Revenue Actual | $1.241B |
Revenue Surprise | Beat by $1241M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.45846 |
EPS GAAP Estimate | $0.45846 |
Revenue Estimate | $1.144109813B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Mar 2030 | 4.815 | 31.96 | 4.62599 | 5.09088 | 3 |
Mar 2029 | 3.44667 | 44.65 | 3.22564 | 3.71459 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.2 | -0.37642 | 1.241B | 25.22% | -41.22M |
FQ4 2024 (Dec 2024) | 0.24 | -0.0916 | 0.983B | 16.17% | 41.35M |
FQ3 2024 (Sep 2024) | 0.1 | -0.25433 | 0.844B | 100% | -93.78M |
FQ2 2024 (Jun 2024) | 0.21 | 0.21 | 0.939B | 100% | 939M |
FQ1 2024 (Mar 2024) | 0.22 | 0.22 | 0.928B | 31.79% | 928M |
FQ4 2022 (Dec 2022) | 0.18 | 0.18 | 0.724B | 100% | 724M |
FQ1 2023 (Mar 2023) | 0.00292382 | 0.00292382 | 0.633B | 100% | 633M |
FQ4 2023 (Dec 2023) | 0.08 | 0.08 | 0.824B | 12.14% | 824M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.45846
Consensus Revenue Estimates
1.144109813B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.79197 | -- | 0.77795 | 0.92516 | 12 |
FQ3 2027 (Sep 2027) | 0.67574 | -- | 0.66378 | 0.78938 | 19 |
FQ2 2027 (Jun 2027) | 0.62674 | -- | 0.61565 | 0.73214 | 10 |
FQ1 2027 (Mar 2027) | 0.65507 | -- | 0.64051 | 0.66551 | 4 |
FQ4 2026 (Dec 2026) | 0.65704 | -- | 0.64243 | 0.66751 | 9 |
FQ3 2026 (Sep 2026) | 0.502 | -- | 0.45314 | 0.54432 | 4 |
FQ2 2026 (Jun 2026) | 0.453 | -- | 0.40891 | 0.49119 | 4 |
FQ1 2026 (Mar 2026) | 0.56659 | 64.7 | 0.55399 | 0.57562 | 4 |
FQ4 2025 (Dec 2025) | 0.54399 | 55.88 | 0.5319 | 0.55266 | 9 |
FQ3 2025 (Sep 2025) | 0.45846 | 78.19 | 0.41383 | 0.49711 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.77B | -- | 1.75B | 2B | 20 |
FQ3 2027 (Sep 2027) | 1.61B | -- | 1.59B | 1.82B | 18 |
FQ2 2027 (Jun 2027) | 1.54B | -- | 1.51B | 1.73B | 17 |
FQ1 2027 (Mar 2027) | 1.5B | -- | 1.47B | 1.52B | 9 |
FQ4 2026 (Dec 2026) | 1.48B | -- | 1.45B | 1.5B | 9 |
FQ3 2026 (Sep 2026) | 3.09B | -- | 2.86B | 3.29B | 8 |
FQ2 2026 (Jun 2026) | 2.88B | -- | 2.67B | 3.07B | 5 |
FQ1 2026 (Mar 2026) | 1.33B | 6.45 | 1.3B | 1.34B | 9 |
FQ4 2025 (Dec 2025) | 1.27B | 22.78 | 1.25B | 1.29B | 8 |
FQ3 2025 (Sep 2025) | 1.14B | 26.23 | 1.06B | 1.22B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.57642 | 0.2 | -0.37642 | -188.21% |
FQ4 2024 (Dec 2024) | 0.3316 | 0.24 | -0.0916 | -38.17% |
FQ3 2024 (Sep 2024) | 0.35433 | 0.1 | -0.25433 | -254.33% |
FQ2 2024 (Jun 2024) | 0.21 | 0.21 | 100% | |
FQ1 2024 (Mar 2024) | 0.22 | 0.22 | 100% | |
FQ4 2022 (Dec 2022) | 0.18 | 0.18 | 100% | |
FQ1 2023 (Mar 2023) | 0.00292382 | 0.00292382 | 100% | |
FQ4 2023 (Dec 2023) | 0.08 | 0.08 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.28B | $1.24B | $-41.22M | -3.32% |
FQ4 2024 (Dec 2024) | $0.94B | $0.98B | $41.35M | 4.21% |
FQ3 2024 (Sep 2024) | $0.94B | $0.84B | $-93.78M | -11.11% |
FQ2 2024 (Jun 2024) | $0B | $0.94B | $939M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.93B | $928M | 100% |
FQ4 2022 (Dec 2022) | $0B | $0.72B | $724M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.63B | $633M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.82B | $824M | 100% |